Argireline is one of the best-known peptides in skincare, sold in serums that promise to soften expression lines. Its story starts with a neuroscience question: could a short peptide imitate part of the protein that botulinum toxin destroys, and quieten the same nerve-to-muscle signal from the surface of the skin?
This guide covers what Argireline and its longer cousin SNAP-8 are, the mechanism behind them, what the published studies actually found, where the evidence runs thin, and what to check before ordering research-grade SNAP-8 in Canada.
The short answer
- Argireline (acetyl hexapeptide-8, formerly acetyl hexapeptide-3) is the six-amino-acid peptide Ac-EEMQRR-NH₂, modelled on the start of SNAP-25, a protein nerve endings need to release acetylcholine.
- It was developed by the Spanish company Lipotec, now part of Lubrizol, and first characterized in a 2002 study.
- The proposed mechanism: by competing with SNAP-25, it weakens the SNARE complex that drives neurotransmitter release, relaxing the small muscle contractions behind expression lines. Botulinum toxin A targets the same machinery by cutting SNAP-25.
- A small 2002 study reported up to 30% shallower wrinkles after 30 days, and a 2013 randomized trial of 60 people reported 48.9% anti-wrinkle efficacy versus 0% for placebo. How well it penetrates skin remains an open question.
- SNAP-8 (acetyl octapeptide-3) adds two amino acids. Claims that it is more active come mainly from manufacturer data.
Argireline and SNAP-8
Both are capped at both ends: an acetyl group at the start and an amide at the end.
Argireline (acetyl hexapeptide-8)
- Ac
- E
- E
- M
- Q
- R
- R
- NH₂
SNAP-8 (acetyl octapeptide-3, also listed as acetyl glutamyl heptapeptide-1)
- Ac
- E
- E
- M
- Q
- R
- R
- A
- D
- NH₂
Blue beads: the two extra residues SNAP-8 takes from the SNAP-25 sequence.
- Modelled on
- The N-terminal end of SNAP-25
- Developer
- Lipotec, Barcelona (now Lubrizol); Argireline launched in 2001
- Target
- The SNARE complex at nerve endings
- Research themes
- Expression lines, neurotransmitter release in cell models
Where the evidence stands
- Cell studies
- Small human studies
- One randomized trial (Argireline)
- Independent replication
SNAP-8 has no independent placebo-controlled trials.
The SNARE idea
When a nerve tells a muscle to contract, it releases acetylcholine from tiny packets called vesicles. To empty a vesicle, three proteins, SNAP-25, syntaxin and VAMP, wind together into a tight bundle called the SNARE complex, which pulls the vesicle against the cell membrane until they fuse.
Botulinum toxin A works by cutting SNAP-25, so the complex cannot form and the muscle relaxes for weeks. Argireline’s designers took the opposite approach: a short copy of SNAP-25’s starting sequence that might slip into the complex in place of the real protein and leave it incomplete. In the 2002 paper that introduced it, Argireline reduced the release of catecholamines from cultured chromaffin cells in a dose-dependent way, the first evidence that the idea could work at the cellular level.
What the studies found
- 2002Blanes-Mira and colleagues report the cell data plus a small, uncontrolled study in which healthy women applied a 10% Argireline emulsion for 30 days. Skin-surface analysis showed wrinkle depth reduced by up to 30% around the eyes, with no irritation reported.
- 2013Wang and colleagues publish a randomized, placebo-controlled trial in the American Journal of Clinical Dermatology. Sixty Chinese adults were randomized 3 to 1 to an Argireline eye cream or placebo, applied twice daily for 4 weeks. Total anti-wrinkle efficacy was 48.9% with Argireline and 0% with placebo.
- Since thenFurther studies have tested formulation and penetration, including Argireline combined with other peptides. SNAP-8’s efficacy figures come mainly from manufacturer testing rather than independent placebo-controlled trials.
Research-grade SNAP-8 with a batch-matched COA.
View SNAP-8The skin-penetration problem
The biggest open question is delivery. The target, the nerve-muscle junction, sits well below the skin surface, and the outer layer of skin is designed to keep molecules out. Tape-stripping studies, which remove skin one thin layer at a time and measure what is left, have found Argireline concentrations falling with each layer, consistent with limited penetration. Researchers have explored formulation changes and delivery methods such as microneedle patches to get more of it through.
That makes the clinical numbers harder to interpret. Some of the measured smoothing could come from the formulation itself, such as moisturizing effects, rather than from SNARE inhibition at nerve endings.
How this compares with botulinum toxin
| Feature | Botulinum toxin A | Argireline and SNAP-8 |
|---|---|---|
| What it is | A large bacterial protein | Short synthetic peptides |
| How it acts on SNAP-25 | Cuts it enzymatically | Proposed to compete with it |
| How it reaches the target | Injected near the muscle | Applied to the skin surface |
| Evidence | Approved medicine with extensive trials | Small studies; one randomized trial for Argireline |
The “topical alternative to injections” framing common in marketing is not supported by the evidence. The shared target is real; equivalence is not.
What is established and what is open
Reasonably well established
- Argireline mimics the N-terminal end of SNAP-25 and inhibits neurotransmitter release in cell models.
- One randomized, placebo-controlled trial reported a measurable anti-wrinkle effect over 4 weeks.
- Topical use at studied concentrations was well tolerated.
Open questions
- How much reaches nerve endings through intact skin.
- Independent replication, especially for SNAP-8.
- Durability of effects beyond a few weeks.
Related peptides in skin research
Argireline and SNAP-8 target muscle signalling. Copper peptides work on a different track entirely: tissue remodelling and gene expression. See our GHK-Cu copper peptide guide, which also covers AHK-Cu.
GHK-CuThe copper tripeptideView product and COA
GHK-Cu + KPVCopper peptide with KPVView product and COA
Sourcing SNAP-8 in Canada
Research-grade SNAP-8 is a laboratory reagent, not a skincare product or a cosmetic formulation. Before ordering from any supplier, check that:
- The mass reflects both end caps. The acetyl group and the C-terminal amide each change the expected mass, so the COA should match the capped octapeptide. See our HPLC testing guide.
- The label says which peptide. Argireline and SNAP-8 differ by two amino acids and are easy to confuse in listings.
- The COA matches your lot. Our peptide COA guide walks through it.
- Storage is cold, dry and dark. Methionine, in both sequences, is prone to oxidation. See our peptide storage guide.
Research use only. SNAP-8 from Pure Peptides Canada is a laboratory reagent. It is not a cosmetic or skincare product, it is not for human or veterinary use, and nothing in this article is cosmetic, dosing or medical guidance.
Frequently asked questions
What is Argireline?
Argireline is the trade name for acetyl hexapeptide-8, formerly called acetyl hexapeptide-3: a six-amino-acid peptide (Ac-EEMQRR-NH2) modelled on the start of SNAP-25. It was developed by Lipotec as a cosmetic ingredient aimed at expression lines.
What is SNAP-8?
SNAP-8, or acetyl octapeptide-3, is an eight-amino-acid extension of Argireline that copies two more residues of the SNAP-25 sequence. Claims that it is more active than Argireline come mainly from manufacturer data.
Is Argireline like Botox?
They share a target, SNAP-25, but work very differently. Botulinum toxin is injected and cuts SNAP-25; Argireline is applied to the skin and is proposed to compete with SNAP-25. The evidence does not support treating them as equivalent.
Does Argireline work?
A small 2002 study reported up to 30% shallower wrinkles after 30 days, and a 2013 randomized trial of 60 people reported 48.9% anti-wrinkle efficacy versus 0% for placebo. The evidence base is small, and how well it penetrates skin is unresolved.
What is the difference between Argireline and SNAP-8?
Argireline has six amino acids; SNAP-8 has eight, adding alanine and aspartic acid from the SNAP-25 sequence. Both are capped with an acetyl group and an amide. Argireline has more independent clinical data.
Does Pure Peptides Canada sell SNAP-8 as skincare?
No. SNAP-8 is sold strictly as a research reagent for laboratory use, with a batch-matched certificate of analysis. It is not a cosmetic product and is not for human use.
Research-grade SNAP-8, tested batch by batch
SNAP-8 and copper peptides with independent COAs, tracked delivery across Canada and pricing in Canadian dollars.
References
- Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002;24(5):303–310. PubMed
- Wang Y, Wang M, Xiao S, et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013. PubMed
For laboratory research use only. Not for human or veterinary use. This article summarizes published research for educational purposes and is not medical or cosmetic advice.